News
Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...
Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.
Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.
Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...
The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.
Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...
Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...
EMED Assembles Top Scientific Advisory Board to Bolster Launch of Breakthrough Infusion Technologies
EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced the members of its Scientific Advisory Board (SAB). Established in 1991, EMED Technologies is a ...
Now that it’s deep summer, heat waves are repeatedly hitting across the country. If you have air conditioning, it makes sense ...
The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative ...
Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...
There was no doctor on-site when a patient arrived in early June at the emergency room in the small hospital at the intersection of two dirt roads in this town of 400 residents. | A recent study found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results